Zhang et al. found that PD-L1-promoted resistance to gefitinib in NSCLC cells was induced by activating the transforming growth factor-β (TGF-β)/Smad pathway to induce Epithelial-Mesenchymal Transition (EMT) [114]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.